Paul Alloway

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bedford, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Paul Alloway
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Paul Alloway

Form 4 holding Former President and Chief Operating Officer of Homology Medicines, Inc.

Q32 Bio Inc.

Security class
Common Stock
Shares / value
2,596
Estimated value
$1,483
Report date
25 Mar 2024
Price
$0.5711
Ownership
Direct
Form 4 holding Former President and Chief Operating Officer of Homology Medicines, Inc.

Homology Medicines, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$0
Report date
25 Mar 2024
Price
$0.5711
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Paul Alloway

4 QTTB

Q32 Bio Inc.

Report period
25 Mar 2024
Transactions
1
Transaction value
-$6,488
Accepted by SEC
23 Apr 2024, 17:03
Role
Former President and Chief Operating Officer of Homology Medicines, Inc.
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .